Tobias Monschein

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Journal: Journal of neurology

Published: March 09, 2026

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

Journal: Frontiers in neurology

Published: February 25, 2026

Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis.

Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: October 01, 2025

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Journal: Neurology

Published: September 29, 2025

Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.

Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 20, 2025

Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.

Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.

Journal: Journal of neurology

Published: July 25, 2025

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Journal: Journal of neurology

Published: July 04, 2025

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis.

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 09, 2025

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center.

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center.

Journal: European journal of neurology

Published: May 27, 2025

SARS-CoV-2 Vaccines and Multiple Sclerosis: An Update.

SARS-CoV-2 Vaccines and Multiple Sclerosis: An Update.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 25, 2025

MuSic Moves-co-creating a music-supported exercise programme with and for people with multiple sclerosis: a bicentre participatory mixed methods study.

MuSic Moves-co-creating a music-supported exercise programme with and for people with multiple sclerosis: a bicentre participatory mixed methods study.

Journal: BMJ open

Published: November 24, 2024

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.

Journal: Annals of clinical and translational neurology

Published: October 19, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026